XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2020   20,839,227    
Balance at beginning of period at Dec. 31, 2020 $ 1,045,252 $ 4,282 $ 707,209 $ 333,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted common stock issued (in shares)   109    
Stock used for tax withholdings (in shares)   (38)    
Exercise of stock options (in shares)   429    
Exercise of stock options 15   15  
Stock-based compensation 1,612   1,612  
Net income (loss) (119)     (119)
Balance at end of period (in shares) at Mar. 31, 2021   20,839,727    
Balance at end of period at Mar. 31, 2021 1,046,760 $ 4,282 708,836 333,642
Balance at beginning of period (in shares) at Dec. 31, 2020   20,839,227    
Balance at beginning of period at Dec. 31, 2020 1,045,252 $ 4,282 707,209 333,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 15,221      
Balance at end of period (in shares) at Sep. 30, 2021   30,858,813    
Balance at end of period at Sep. 30, 2021 1,417,250 $ 4,378 1,085,968 326,904
Balance at beginning of period (in shares) at Mar. 31, 2021   20,839,727    
Balance at beginning of period at Mar. 31, 2021 1,046,760 $ 4,282 708,836 333,642
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance pursuant to acquisition (in shares)   9,802,166    
Issuance pursuant to acquisition 374,933 $ 98 374,835  
Restricted common stock issued (in shares)   261,539    
Stock used for tax withholdings (in shares)   (70,330)    
Stock used for tax withholdings (2,816) $ (2) (2,814)  
Exercise of stock options (in shares)   11,523    
Exercise of stock options 394   394  
Stock-based compensation 2,195   2,195  
Cash dividends and Dividends declared (11,033)     (11,033)
Net income (loss) (25,319)     (25,319)
Balance at end of period (in shares) at Jun. 30, 2021   30,844,625    
Balance at end of period at Jun. 30, 2021 1,385,114 $ 4,378 1,083,446 297,290
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted common stock issued (in shares)   5,987    
Stock used for tax withholdings (in shares)   (1,725)    
Stock used for tax withholdings (74)   (74)  
Exercise of stock options (in shares)   9,926    
Exercise of stock options 307   307  
Stock-based compensation 2,289   2,289  
Cash dividends and Dividends declared (11,045)     (11,045)
Net income (loss) 40,659     40,659
Balance at end of period (in shares) at Sep. 30, 2021   30,858,813    
Balance at end of period at Sep. 30, 2021 1,417,250 $ 4,378 1,085,968 326,904
Balance at beginning of period (in shares) at Dec. 31, 2021   84,572,846    
Balance at beginning of period at Dec. 31, 2021 4,654,998 $ 4,912 4,199,108 450,978
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted common stock issued (in shares)   579,229    
Restricted common stock issued 6 $ 6    
Stock used for tax withholdings (in shares)   (215,811)    
Stock used for tax withholdings (12,934) $ (2) (12,932)  
Exercise of stock options (in shares)   5,294    
Exercise of stock options 178   178  
Stock-based compensation 8,090   8,090  
Cash dividends and Dividends declared (104,444)     (104,444)
Net income (loss) 91,639     91,639
Balance at end of period (in shares) at Mar. 31, 2022   84,941,558    
Balance at end of period at Mar. 31, 2022 4,637,533 $ 4,916 4,194,444 438,173
Balance at beginning of period (in shares) at Dec. 31, 2021   84,572,846    
Balance at beginning of period at Dec. 31, 2021 4,654,998 $ 4,912 4,199,108 450,978
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 966,212      
Balance at end of period (in shares) at Sep. 30, 2022   85,105,363    
Balance at end of period at Sep. 30, 2022 5,253,525 $ 4,917 4,204,742 1,043,866
Balance at beginning of period (in shares) at Mar. 31, 2022   84,941,558    
Balance at beginning of period at Mar. 31, 2022 4,637,533 $ 4,916 4,194,444 438,173
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted common stock issued (in shares)   130,309    
Restricted common stock issued 1 $ 1    
Stock used for tax withholdings (in shares)   (40,646)    
Stock used for tax withholdings (2,813)   (2,813)  
Exercise of stock options (in shares)   742    
Exercise of stock options 24   24  
Stock-based compensation 6,135   6,135  
Cash dividends and Dividends declared (117,151)     (117,151)
Net income (loss) 468,821     468,821
Balance at end of period (in shares) at Jun. 30, 2022   85,031,963    
Balance at end of period at Jun. 30, 2022 4,992,550 $ 4,917 4,197,790 789,843
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted common stock issued (in shares)   125,381    
Restricted common stock issued 1 $ 1    
Stock used for tax withholdings (in shares)   (52,879)    
Stock used for tax withholdings (3,323) $ (1) (3,322)  
Exercise of stock options (in shares)   898    
Exercise of stock options 30   30  
Stock-based compensation 10,244   10,244  
Cash dividends and Dividends declared (151,729)     (151,729)
Net income (loss) 405,752     405,752
Balance at end of period (in shares) at Sep. 30, 2022   85,105,363    
Balance at end of period at Sep. 30, 2022 $ 5,253,525 $ 4,917 $ 4,204,742 $ 1,043,866